Loading clinical trials...
Loading clinical trials...
The response to vaccination for hepatitis is reduced in patients with HIV infection. The hypothesis of the study is that adjuvant interleukin-2 administered subcutaneously at the time of vaccination i...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Aalborg University Hospital
NCT06853314 · HIV Infections, Alcohol Use Disorder, and more
NCT06092333 · Chronic Hepatitis B
NCT06868641 · HIV Infections
NCT05633056 · Multi Drug Resistant Tuberculosis, HIV Infections
NCT04914611 · Hepatitis B
Department of Infectious Diseases, Aalborg Hospital
Aalborg
Department of Infectious Diseases, Skejby Hospital
Aarhus
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions